In the diagnosis of neonatal sepsis importance of gelsolin and relationship with mortality and morbidity

Medical Hypotheses

Volumn 94, Issue , 2016, Pages 77-80

  Halis, Hülya ^a   Gunes, Tamer ^a   Korkut, Sabriye ^a   Saraymen, Berkay ^a   Şen, Ahmet ^a   Bastug, Osman ^a   Öztürk, Adnan ^a   Kurtoğlu, Selim ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Gelsolin; Neonatal sepsis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GELSOLIN; ACTIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; TEICHOIC ACID;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOTHESIS; INFANT; LEUKOCYTE; MALE; MULTIPLE ORGAN FAILURE; NECROTIZING ENTEROCOLITIS; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN SEPSIS; PNEUMOTHORAX; PREMATURITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; AREA UNDER THE CURVE; BLOOD; METABOLISM; MORBIDITY; MORTALITY; NEONATAL SEPSIS; NEUTROPHIL; NEWBORN; PATHOPHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; SEPSIS;

ACTINS; AREA UNDER CURVE; BIOMARKERS; FEMALE; GELSOLIN; HUMANS; INFANT, NEWBORN; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MALE; MORBIDITY; NEONATAL SEPSIS; NEUTROPHILS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEPSIS; TEICHOIC ACIDS;

EID: 84977580877     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2016.06.017     Document Type: Article

References (25)

1. [1] Osborn, T.M., Verdrengh, M., Stossel, T.P., Tarkowski, A., Bokarewa, M., Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis. Arthritis Res Ther, 10, 2008, 117.
2. [2] Peddada, N., Sagar, A., Ashish, G.R., Plasma gelsolin: a general prognostic marker of health. Med Hypotheses 78 (2012), 203–210.
3. [3] Li, G.H., Arora, P.D., Chen, Y., McCulloch, C.A., Liu, P., Multifunctional roles of gelsolin in health and diseases. Med Res Rev 32 (2010), 999–1025.
4. [4] Wang, H., Cheng, B., Chen, Q., Wu, S., Lv, C., Xie, G., Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients. Crit Care, 12, 2008, 106.
5. [5] Mounzer, K.C., Moncure, M., Smith, Y.R., Dinubile, M.J., Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma. Am J Respir Crit Care Med 160 (1999), 1673–1681.
6. [6] Smith, D.B., Janmey, P.A., Herbert, T.J., Lind, S.E., Quantitative measurement of plasma gelsolin and its incorporation into fibrin clots. J Lab Clin Med 110 (1987), 189–195.
7. [7] Sezen, D., Bongiovanni, A.M., Gelber, S., et al. Gelsolin downregulates lipopolysaccharide-induced intraamniotic tumor necrosis factor-alpha production in the midtrimester of pregnancy. Am J Obstet Gynecol, 200, 2009, 191.
8. [8] Ohnishi, M., Matsumoto, T., Nagashio, R., et al. Proteomics of tumor-specific proteins in cerebrospinal fluid of patients with astrocytoma: usefulness of gelsolin protein. Pathol Int 59 (2009), 797–803.
9. [9] Lee, W.M., Galbraith, R.M., The extracellular actin-scavenger system and actin toxicity. N Engl J Med 326 (1992), 1335–1341.
10. [10] Lind, S.E., Smith, D.B., Janmey, P.A., Stossel, T.P., Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation. J Clin Invest 78 (1986), 736–742.
11. [11] Vasconcellos, C.A., Allen, P.G., Wohl, M.E., Drazen, J.M., Janmey, P.A., Stossel, T.P., Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 263 (1994), 969–971.
12. [12] Suhler, E., Lin, W., Yin, H.L., Lee, W.M., Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis. Crit Care Med 25 (1997), 594–598.
13. [13] Lee, P.S., Waxman, A.B., Cotich, K.L., Chung, S.W., Perrella, M.A., Stossel, T.P., Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 35 (2007), 849–855.
14. [14] Christofidou-Solomidou, M., Scherpereel, A., Solomides, C.C., et al. Recombinant plasma gelsolin diminishes the acute inflammatory response to hyperoxia in mice. J Investig Med 50 (2002), 54–60.
15. [15] Rothenbach, P.A., Dahl, B., Schwartz, J.J., et al. Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol 96 (2004), 25–31.
16. [16] Töllner, U., Early diagnosis of septicemia in the newborn. Clinical studies and sepsis score. Eur J Pediatr 138 (1982), 331–337.
17. [17] Bucki, R., Kulakowska, A., Byfield, F.J., et al. Plasma gelsolin modulates cellular response to sphingosine 1-phosphate. Am J Physiol Cell Physiol 299 (2010), 1516–1523.
18. [18] Osborn, T.M., Dahlgren, C., Hartwig, J.H., Stossel, T.P., Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Am J Physiol Cell Physiol 292 (2007), 1323–1330.
19. [19] Lind, S.E., Janmey, P.A., Human plasma gelsolin binds to fibronectin. J Biol Chem 259 (1984), 13262–13266.
20. [20] Bucki, R., Byfield, F.J., Kulakowska, A., et al. Extracellular gelsolin binds lipoteichoic acid and modulates cellular response to proinflammatory bacterial wall components. J Immunol 181 (2008), 4936–4944.
21. [21] Cohen, T.S., Bucki, R., Byfield, F.J., et al. Therapeutic potential of plasma gelsolin administration in a rat model of sepsis. Cytokine 54 (2011), 235–238.
22. [22] Lee, P.S., Patel, S.R., Christiani, D.C., Bajwa, E., Stossel, T.P., Waxman, A.B., Plasma gelsolin depletion and circulating actin in sepsis: a pilot study. PLoS ONE, 3, 2008, e3712.
23. [23] Mounzer, K.C., Moncure, M., Smith, Y.R., Dinubile, M.J., Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma. Am J Respir Crit Care Med 160 (1999), 1673–1681.
24. [24] Wang, H., Cheng, B., Chen, Q., et al. Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients. Crit Care, 12, 2008, R106.
25. [25] Kose, M., Elmas, T., Gokahmetoglu, S., et al. The predictive value of gelsolin for the outcomes of preterm neonates: a pilot study. Pediatr Int 56 (2014), 856–859.